Belonging to the Epidermal Growth Factor Receptor (EGF/EGFR) family, the ERBB2/Human Epidermal Growth Factor Receptor 2 (HER2) receptor signaling pathway has a well-documented role in driving aggressive, metastatic breast cancers when aberrantly activated [5]. The gene discussed is EGFR; the disease is breast cancer.